Hyperlipidemia
📧 Sign up to get email alerts when something new happens for Hyperlipidemia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2024-10-15FDA Approved: ROSUVASTATIN CALCIUM — Supplemental Application (Glenmark Pharmaceutials Inc., USA)
FDA approved a supplemental application for rosuvastatin calcium from Glenmark Pharmaceuticals, confirming regulatory approval of this gener…
-
FDA approval · 2024-10-11FDA Approved: COLESEVELAM HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved a supplemental application for Colesevelam hydrochloride from Amneal Pharmaceuticals of New York LLC.
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: Xian-Hua-Cha for Relieving Hyperlipidemia With Obesity [Phase 3]
Phase 3 clinical trial update for Xian-Hua-Cha evaluating treatment of hyperlipidemia with obesity. The current study status is unknown.
-
CLINICAL_TRIALS research · 2024-10-03Clinical Trial Update: AdLip: Human Coach-supported Digital/AI Personal Health Assistant to Improve Adherence to Lipid-Lowering Medication [NA]
This ClinicalTrials.gov entry describes an ongoing study of AdLip, a digital/AI personal health assistant with human coaching aimed at impro…
-
CLINICAL_TRIALS trial_result · 2024-09-27Clinical Trial Update: Study to Evaluate the Effect of Food on the Pharmacokinetics of ASC41 in Healthy Volunteers [Phase 1]
A Phase 1 trial completed to evaluate the effect of food on the pharmacokinetics of ASC41 in healthy volunteers, with study context includin…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-09-27Clinical Trial Update: Study to Evaluate the Safety and Efficacy of ASC41 in Overweight and Obese Subjects [Phase 1]
Completed Phase 1 trial evaluating the safety and initial efficacy of ASC41 in overweight and obese subjects, including participants with NA…
-
FDA approval · 2024-09-23FDA Approved: EZETIMIBE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for ezetimibe submitted by Sandoz Inc, updating the approved ezetimibe product.
-
CLINICAL_TRIALS trial_result · 2024-09-23Clinical Trial Update: Effect of Lactose on Blood Lipids [NA]
Completed clinical trial evaluating the effect of lactose on blood lipid levels.
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Effect of Small Interfering RNA Inclisiran on Carotid Plaques As Assessed by Carotid Ultrasound [Phase 4]
A Phase 4 clinical trial is evaluating inclisiran, a small interfering RNA, for effects on carotid plaques assessed by carotid ultrasound; t…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Plant Sterol-Enriched Palm Oil to Improve Lipid Profile and Inflammation in Hyperlipidemic Individuals [NA]
Completed clinical trial evaluating plant sterol-enriched palm oil for improving lipid profile and inflammation in individuals with hyperlip…
-
CLINICAL_TRIALS trial_result · 2024-09-03Clinical Trial Update: Pragmatic Trial of Messaging to Providers About Treatment of Hyperlipidemia (PROMPT-LIPID) [NA]
This update reports the completion and results posting of PROMPT-LIPID, a pragmatic trial assessing whether targeted messaging to providers …
-
CLINICAL_TRIALS trial_result · 2024-09-03Clinical Trial Update: Influence of TyG Index and TG/HDL-C Ratio on Fetal Macrosomia
A completed clinical trial examined whether the triglyceride-glucose (TyG) index and TG/HDL-C ratio correlate with fetal macrosomia.
-
FDA approval · 2024-08-22FDA Approved: FENOFIBRATE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for fenofibrate submitted by Aurobindo Pharma Limited, relating to a generic fenofibrate product.
-
FDA approval · 2024-08-20FDA Approved: REPATHA — Supplemental Application (Amgen USA Inc.)
FDA approves a supplemental application for Repatha (evolocumab) from Amgen USA Inc., authorizing changes related to its labeling/indication…
-
FDA approval · 2024-08-20FDA Approved: PITAVASTATIN — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals LLC's original application for pitavastatin (generic), authorizing its manufacture and sale as a statin …
-
FDA approval · 2024-08-16FDA Approved: COLESTIPOL HYDROCHLORIDE — Original Application (Edenbridge Pharmaceuticals LLC.)
FDA approved the original application for colestipol hydrochloride from Edenbridge Pharmaceuticals LLC, a generic product. The drug is used …
-
FDA approval · 2024-08-15FDA Approved: EZETIMIBE — Supplemental Application (Ascend Laboratories, LLC)
FDA approves Ascend Laboratories, LLC's supplemental application for ezetimibe.
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: A Crossover Study to Evaluate the Efficacy of Simvastatin in Elevating HDL-C Levels in Patients With Type 2 Diabetes (0733-216)(COMPLETED) [Phase 3]
A completed Phase 3 crossover study evaluating whether simvastatin elevates HDL cholesterol in patients with type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: TWICE (Ezetimibe Together With Any Statin Cholesterol Enhancement)(0653-060) [Phase 3]
Completed Phase 3 trial TWICE evaluated ezetimibe together with any statin for lowering cholesterol in hypercholesterolemia and hyperlipidem…
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: Sitosterolemia Extension Study (0653-004)(COMPLETED) [Phase 3]
A Phase 3 extension study for sitosterolemia (0653-004) sponsored by Organon and Co has completed; the snippet does not include efficacy or …
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: A Study to Evaluate an Investigational Drug in Patients With Mixed Hyperlipidemia (0653A-071)(COMPLETED) [Phase 3]
A Phase 3 clinical trial evaluating an investigational drug (0653A-071) for mixed hyperlipidemia has completed; the study enrolled patients …
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: Vytorin As Strategy To Reduce Dislipidemia In Adults (0653A-148) [Phase 3]
A Phase 3 trial update for Vytorin (ezetimibe/simvastatin) in adults with hyperlipidemia has completed.
-
CLINICAL_TRIALS trial_result · 2024-08-12Clinical Trial Update: Study to Investigate Safety, Tolerability, PK and PD Response of SLN360 in Subjects With Elevated Lipoprotein(a) [Phase 1]
A Phase 1 study evaluating the safety, tolerability, PK and PD of SLN360 in subjects with elevated lipoprotein(a) has completed.
-
CLINICAL_TRIALS trial_result · 2024-08-09Clinical Trial Update: Veteran Peer Coaches Optimizing and Advancing Cardiac Health [NA]
ClinicalTrials.gov reports the completion of the Veteran Peer Coaches program aimed at optimizing and advancing cardiac health, with results…
-
CLINICAL_TRIALS trial_result · 2024-08-09Clinical Trial Update: Metabolic Syndrome and Related Diseases in Healthcare Workers
A completed clinical trial evaluated metabolic syndrome and related conditions in healthcare workers. The study encompassed metabolic syndro…